RHYTHM PHARMACEUTICALS, INC. Capital Expenditures
RHYTHM PHARMACEUTICALS, INC. (RYTM) reported Capital Expenditures of $953.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-02-26
- RHYTHM PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for the quarter ending 2023-12-31 was -$1.00K.
- RHYTHM PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for the quarter ending 2023-09-30 was $1.00K, a 98.95% decline year-over-year.
- RHYTHM PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- RHYTHM PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for the quarter ending 2023-03-31 was $47.00K, a 62.99% decline year-over-year.
- RHYTHM PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for fiscal 2025 was $953.00K.
- RHYTHM PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- RHYTHM PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for fiscal 2023 was $47.00K, a 83.27% decline from fiscal 2022.
- RHYTHM PHARMACEUTICALS, INC. payments to acquire property, plant, and equipment for fiscal 2022 was $281.00K, a 35.25% decline from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2025-12-31 | $953.00K 10-K · filed 2026-02-26 | |||
| 2024-12-31 | $0.00 10-K · filed 2026-02-26 | |||
| 2023-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 derived: sum of 2 quarters · filed 2026-02-26 | $0.00 derived: sum of 3 quarters · filed 2026-02-26 | $47.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $1.00K derived: sum of 2 quarters · filed 2024-11-06 | $48.00K 10-Q · filed 2024-11-06 | $47.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $47.00K 10-Q · filed 2024-08-06 | $46.00K derived: sum of 3 quarters · filed 2025-02-28 | $141.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $47.00K 10-Q · filed 2024-05-07 | $46.00K derived: sum of 2 quarters · filed 2025-02-28 | $141.00K derived: sum of 3 quarters · filed 2025-02-28 | $201.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $94.00K derived: sum of 2 quarters · filed 2025-02-28 | $154.00K derived: sum of 3 quarters · filed 2025-02-28 | $281.00K 10-K · filed 2025-02-28 |
| 2022-09-30 | $95.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $155.00K derived: sum of 2 quarters · filed 2023-11-08 | $282.00K 10-Q · filed 2023-11-08 | $350.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $60.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $187.00K 10-Q · filed 2023-08-01 | $255.00K derived: sum of 3 quarters · filed 2024-02-29 | $361.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $127.00K 10-Q · filed 2023-05-02 | $195.00K derived: sum of 2 quarters · filed 2024-02-29 | $301.00K derived: sum of 3 quarters · filed 2024-02-29 | $549.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $68.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $174.00K derived: sum of 2 quarters · filed 2024-02-29 | $422.00K derived: sum of 3 quarters · filed 2024-02-29 | $434.00K 10-K · filed 2024-02-29 |
| 2021-09-30 | $106.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $354.00K derived: sum of 2 quarters · filed 2022-11-08 | $366.00K 10-Q · filed 2022-11-08 | $450.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $248.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $260.00K 10-Q · filed 2022-08-03 | $344.00K derived: sum of 3 quarters · filed 2023-03-01 | |
| 2021-03-31 | $12.00K 10-Q · filed 2022-05-03 | $96.00K derived: sum of 2 quarters · filed 2023-03-01 | ||
| 2020-12-31 | $84.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $214.00K 10-K · filed 2023-03-01 | ||
| 2020-09-30 | $130.00K 10-Q · filed 2021-11-02 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $259.00K derived: sum of 2 quarters · filed 2021-03-01 | $2.57M derived: sum of 3 quarters · filed 2021-03-01 | $3.38M 10-K · filed 2021-03-01 |
| 2019-09-30 | $259.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $2.57M derived: sum of 2 quarters · filed 2020-11-02 | $3.38M 10-Q · filed 2020-11-02 | $3.78M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $2.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-03 | $3.13M 10-Q · filed 2020-08-03 | $3.52M derived: sum of 3 quarters · filed 2021-03-01 | $3.84M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $811.00K 10-Q · filed 2020-05-04 | $1.21M derived: sum of 2 quarters · filed 2021-03-01 | $1.52M derived: sum of 3 quarters · filed 2021-03-01 | |
| 2018-12-31 | $395.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $712.00K derived: sum of 2 quarters · filed 2021-03-01 | $722.00K 10-K · filed 2021-03-01 | |
| 2018-09-30 | $317.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-01 | $327.00K 10-Q · filed 2019-11-01 | ||
| 2018-06-30 | $10.00K 10-Q · filed 2019-07-29 | |||
| 2017-12-31 | $55.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $133.00K 10-K · filed 2020-03-02 | ||
| 2017-09-30 | $78.00K 10-Q · filed 2018-11-09 | |||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | $1.06M 10-K · filed 2019-03-08 | ||
| 2016-09-30 | $1.06M 10-Q · filed 2017-11-14 | |||
| 2015-12-31 | $17.00K 8-K · filed 2018-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |